Bad Blood

John Carreyrou’s novel Bad Blood chronicles the story of Theranos, the company started by Stanford-dropout and prodigy Elizabeth Holmes that reached a peak valuation of $10 billion. I started this book and couldn’t put it down.

It was pretty shocking to read about the level of deception and dishonesty perpetrated by the company and continually tolerated by partner companies, the Theranos legal team, and the company’s many high-profile investors. The book is definitely worth the read and will surely be a business school case study on due diligence and corporate responsibility for years to come.